(NASDAQ:VERO), TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2025. Summary of Financial Results & Recent Progress: Energy Based Device (“EBD”) revenues showing signs of stabilization. Total EBD […]
(Neo:ABXX.NE),(OTC US:ABXXF),(Other OTC:ABXXF), TORONTO and VADUZ, Liechtenstein, Nov. 13, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX) (“Abaxx” or the “Company“), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing“), and producer of the SmarterMarkets(TM) Podcast,
(NasdaqGM:AURA), Aura Provides Phase 3 CoMpass Trial Completion Guidance: 2026 Enrollment Completion and Q4 2027 Topline Data Readout for the 15-Month Primary Endpoint Immune Profiling Data Reveal Bel-sar's Potential to Convert 'Cold' to 'Hot' Tumors, Supporting a Frontline Therapy Across the Bladder Cancer Spectrum; Phase 1b/2 Trial is on Track for Data Mid-2026 BOSTON, Nov.
Phaos Technology Announces Pricing of Initial Public Offering GlobeNewswire November 13, 2025 SINGAPORE, Nov. 13, 2025 (GLOBE NEWSWIRE) — Phaos Technology Holdings (Cayman) Limited, (NYSE American: POAS), (“Phaos” or “the Company”), a leader in advanced microscopy solutions headquartered in Singapore, today announced the pricing of its initial public offering of an aggregate 3,600,090 of its
(TSX:KPT), MISSISSAUGA, Ontario, Nov. 13, 2025 (GLOBE NEWSWIRE) — KP Tissue Inc. (KPT) (TSX: KPT) reports the Q3 2025 financial and operational results of KPT and Kruger Products Inc. (Kruger Products or the Company). Kruger Products is Canada's leading manufacturer of quality tissue products for the Consumer market (Cashmere(R), Purex(R), SpongeTowels(R), Scotties(R), White Swan(R) and
Mobilicom Provides Third Quarter 2025 Update and Financial Highlights: Substantial Increase in Sales to U.S. Market GlobeNewswire November 13, 2025 63% quarter-over-quarter increase in revenues; 84% of Q3 revenues from the U.S. market Robust balance sheet with $16.4 M in cash and cash equivalents, no debt, low burn rate provides ample runway to cash flow
Applied Therapeutics Reports Third Quarter 2025 Financial Results GlobeNewswire November 13, 2025 – Update on regulatory strategy for govorestat for the treatment of CMT-SORD following receipt of Type C meeting minutes – Meeting scheduled with the FDA in 4Q 2025 to discuss govorestat for the treatment of Classic Galactosemia – New data on govorestat for
Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management GlobeNewswire November 13, 2025 Dallas, Texas, Nov. 13, 2025 (GLOBE NEWSWIRE) — Mangoceuticals, Inc. (NASDAQ: MGRX) (“Mangoceuticals” or the “Company”), a company focused on developing, marketing, and selling a variety of health and wellness products via
(NASDAQ:IPSC), Allo-Evasion(TM) 5.0-engineered iPSC beta islets are designed to overcome immune rejection and provide durable glucose control without chronic immunosuppression Compelling preclinical data demonstrate rapid reversal of diabetes and sustained normoglycemia, human Câ€'peptide production and mature GSIS, supported by scalable bioreactor-based manufacturing Investigational New Drug (IND)-enabling studies on track to initiate by year-end 2025; IND
Beamr Issues Q3-2025 CEO Letter to Shareholders: Advancing the Commercial Pipeline in the Autonomous Vehicles Industry GlobeNewswire November 13, 2025 Herzliya, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, today issued a Letter to Shareholders from Sharon Carmel, Chief Executive Officer. Dear Shareholders: